Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders. Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (approximately 4 days) and chronic (approximately 24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect. Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dosage of 18 mg/kg/day have been shown to be in the upper range of the therapeutic dose of fluoxetine administered to humans.16”
From Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression (2025) · cites this paper as [16]
In the citing paper
“Hyponeophagia (novelty-suppressed feeding) has also been used to assess anxiety-like behavior in rodents; in a novel environment, hungry mice exhibit an increased latency to feed that is sensitive to benzodiazepines and SSRIs47,48.”
From Resolving the neural circuits of anxiety (2015) · cites this paper as [47]
In the citing paper
“The NIH paradigm is a sensitive measure for potential anxiolytic drugs and anxiogenic effects of withdrawal on both acute and extended drug administration paradigms (Dulawa et al., 2004;Dulawa and Hen, 2005).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Dulawa et al., 2004
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“We have previously shown that steady state for both fluoxetine and norfluoxetine is achieved by 5 days of receiving fluoxetine in the drinking water (10 mgskgsday), as serum levels after 5 or 90 days of treatment are equivalent (”
BackgroundSelf-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“The intake of palatable fluids, including sucrose and saccharin solutions, has been used as a measure of reward sensitivity (”
MethodAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513 · cited 1×
“These long-term effects are thought to involve increases in neural plasticity and growth-related events (”
BackgroundLucki, I., Dalvi, A., & Mayorga, A. (2001) · Psychopharmacology · doi:10.1007/s002130100694 · Cited by 506 · cited 1×
“Previous reports have shown that acute injection of 10 mgskg fluoxetine reduces immobility in BALBsc mice (”
ResultThe effects of chronic antidepressant treatment in an animal model of anxiety
Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437
Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli
Dulawa, S. C., Grandy, D. K., Low, M. J., Paulus, M. P., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09550.1999 · Cited by 431
Self-citationGriebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000) · Psychopharmacology · doi:10.1007/s002130050038 · Cited by 420
Detke, M. J., & Lucki, I. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00067-8 · Cited by 357 · cited 1×
“The modifications to the test are increasing the water depth (”
BackgroundDo animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347 · cited 1×
“Although some acute paradigms, such as the forced swim and tail suspension tests, provide good assay models for screening antidepressant compounds, few models have been developed in which chronic, but not acute, antidepressant treatment alters behavior (”
BackgroundAnimal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
Conti, A. C., Cryan, J. F., Dalvi, A., Lucki, I., & Blendy, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03262.2002 · Cited by 328
Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression.
Detke, M. J., Johnson, J., & Lucki, I. (1997) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.5.2.107 · Cited by 317 · cited 1×
“Only one report has found antidepressant effects of chronic, but not acute, low dose fluoxetine or desipramine treatment in rats (”
BackgroundAntidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
Cryan, J. F., & Lucki, I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 293
Belzung, C., & Le Pape, G. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90311-5 · Cited by 291
Moreau, J.-L., Jenck, F., Martin, J. R., Mortas, P., & Haefely, W. E. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90035-7 · Cited by 250
The pharmacology of putative early-onset antidepressant strategies
Blier, P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00173-6 · Cited by 244 · cited 1×
“While acute antidepressant treatment increases synaptic monoamines within minutes to hours, weeks of sustained treatment are required for induction of therapeutic effects (”
BackgroundBehavioral and physiological mouse assays for anxiety: a survey in nine mouse strains
Bouwknecht, J. A., & Paylor, R. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00200-0 · Cited by 209
Caccia, S., Cappi, M., Fracasso, C., & Garattini, S. (1990) · Psychopharmacology · doi:10.1007/bf02244004 · Cited by 207 · cited 1×
“The serum fluoxetine levels of chronically treated BALBsc mice were consistent with reports that fluoxetine exhibits nonlinear kinetics, as indicated by a disproportionate increase in its blood concentrations after dose escalation (”
BackgroundCryan, J. F., Page, M. E., & Lucki, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01628-4 · Cited by 185
“Free” versus “Forced” Exploration of a Novel Situation by Rats
Welker, W. I. (1957) · Psychological Reports · doi:10.2466/pr0.1957.3.g.95 · Cited by 173 · cited 1×
“The open field test is a classical approachsavoidance paradigm in which the novel environment concurrently evokes both anxiety and exploration (”
BackgroundA ‘crash’ course on psychostimulant withdrawal as a model of depression
Barr, A. M., Markou, A., & Phillips, A. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02086-2 · Cited by 172
How valuable are animal models in defining antidepressant activity?
Bourin, M., Fiocco, A. J., & Clenet, F. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.178 · Cited by 158 · cited 1×
“Of those, none have strong predictive validity and high reliability while maintaining ease of use (”
BackgroundHome cage activity and behavioral performance in inbred and hybrid mice
Tang, X., Orchard, S. M., & Sanford, L. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00228-0 · Cited by 158
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Merali, Z., Levac, C., & Anisman, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01827-9 · Cited by 157
Bilkei-Gorzo, A., Racz, I., Michel, K., & Zimmer, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10046.2002 · Cited by 152
Borsini, F., Lecci, A., Sessarego, A., Frassine, R., & Meli, A. (1989) · Psychopharmacology · doi:10.1007/bf00442247 · Cited by 118 · cited 1×
“For chronic and subchronic fluoxetine studies in BALBsc mice, mice were pre-exposed to the forced swim test for 6 min 24 h before test day to increase sensitivity for detecting antidepressant behavioral effects (”
MethodYilmazer‐Hanke, D., Roskoden, T., Zilles, K., & Schwegler, H. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00107-4 · Cited by 110
Ohl, F., Roedel, A., Binder, E., & Holsboer, F. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02436.x · Cited by 110 · cited 1×
“Yilmazer-Hanke et al , 2003 ) and hole-board tests (”
Kokkinidis, L., Zacharko, R. M., & Predy, P. A. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90242-7 · Cited by 109 · cited 1×
“For example, desipramine and low dose fluoxetine do not alter intracranial self-stimulation reward thresholds unless animals have undergone drug withdrawal (”
BackgroundDesmethylimipramine attenuates cocaine withdrawal in rats
Markou, A., Hauger, R. L., & Koob, G. F. (1992) · Psychopharmacology · doi:10.1007/bf02245878 · Cited by 98
Thompson, M. R., Li, K. M., Clemens, K. J., Gurtman, C. G., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300347 · Cited by 89
Rénéric, J.-P., Bouvard, M. P., & Stinus, L. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00203-6 · Cited by 87 · cited 1×
“Studies comparing the acute and chronic effects of SSRIs in the forced swim test have reported comparable behavioral effects at the two timepoints both in rats (”
BackgroundKarolewicz, B., & Paul, I. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00830-5 · Cited by 83 · cited 1×
“Mice were then tested in the forced swim test before the novelty-induced hypophagia test because singly housing mice has been reported to prevent antidepressant effects in the forced swim test (”
MethodAlcaro, A., Cabib, S., Ventura, R., & Puglisi‐Allegra, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1161-8 · Cited by 78 · cited 1×
“These long-term effects are thought to involve increases in neural plasticity and growth-related events (”
BackgroundShephard, R. A., & Broadhurst, P. L. (1982) · Psychopharmacology · doi:10.1007/bf00433744 · Cited by 77 · cited 1×
“These paradigms use the reduction in feeding that is observed when a rodent is exposed to a novel environment as an anxiety measure (”
BackgroundEffect of Clinical Doses of Fluoxetine on Psychological Variables in Healthy Volunteers
Gelfin, Y., Gorfine, M., & Lerer, B. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.290 · Cited by 77
Suckow, R. F., Zhang, M. F., & Cooper, T. B. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1756 · Cited by 66
Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects
Barr, L. C., Heninger, G. R., Goodman, W., Charney, D. S., & Price, L. H. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00224-7 · Cited by 62 · cited 1×
“The open field test is a classical approachsavoidance paradigm in which the novel environment concurrently evokes both anxiety and exploration (”
BackgroundDeficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia
Pen, G. L., Gaudet, L., Mortas, P., Mory, R., & Moreau, J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1092-4 · Cited by 59
Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.11.1450 · Cited by 56
Comparative analysis of the anxiety-related behaviors in four inbred mice
Kim, S., Lee, S., Ryu, S., Suk, J.-G., & Park, C. (2002) · Behavioural Processes · doi:10.1016/s0376-6357(02)00085-2 · Cited by 55 · cited 1×
“The BALBsc strain has been shown to be highly emotional, or anxious, relative to other strains in many classical approachsavoidance paradigms including the open field test (”
BackgroundEffects of Melatonin on Neophobic Responses in Different Strains of Mice
Kopp, C., Vogel, E., Rettori, M., Delagrange, P., Lemaître, B. J., & Misslin, R. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00023-4 · Cited by 43 · cited 1×
“Bouwknecht and Paylor, 2002 ), free-exploration tests (”
Kelliher, P., Kelly, J. P., Leonard, B. E., & Sánchez, C. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00026-4 · Cited by 33
Research works printed but not linked: 2
- Hirschfeld R, Weisssman M (2002). Risk factors for major depression and bipolar disorder. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 1018–1025.
- Merikangas K, Pine D (2002). Genetic and other vulnerability factors for anxiety and stress disorders. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 868–882.
Cited by
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish
Egan, R. J., Bergner, C. L., Hart, P. C., Cachat, J. M., Canavello, P. R., Elegante, M. F., Elkhayat, S. I., Bartels, B. K., Tien, A. K., Tien, D. H., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.022 · Cited by 1,376
“Behavioral and physiological data from this study agree strongly with that seen in previously published in rodent studies showing that chronic exposure to fluoxetine reduces anxiety [43,44], corticosterone responses (mice [44]) and HPA sensitivity (rats [45,46]).”
ResultGenetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
“Behavioral Testing Open Field This test was performed as described previously (Dulawa et al., 2004).”
MethodSelf-citationThe ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Metadata
- Authors
- Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R.
- Affiliations
- Columbia University (US)
- Venue
- Neuropsychopharmacology
- Published
- 2004-04-07
- Volume
- 29
- Issue
- 7
- Pages
- 1321-1330
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987972424
- Cited by
- 671
- References
- 50
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 27 · 2023: 28 · 2022: 32 · 2021: 32 · 2020: 31 · 2019: 51 · 2018: 31 · 2017: 42 · 2016: 34 · 2015: 42 · 2014: 41 · 2013: 44 · 2012: 28
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression (MH068542-1)
- National Institutes of Health (5r01da009862-08, 5f32mh065791-02)
- National Institute of Mental Health (F32-MH65791-01A1, P50MH050733, P50-MH50733, R01 MH068542-1, R01MH068542)
- National Institute on Drug Abuse (R01 DA09862)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, chronic antidepressant treatment, anxiety, depression, selective serotonin reuptake inhibitors, inbred mouse strains, BALB/c mice, forced swim test, novelty-induced hypophagia, locomotor activity, antidepressant sensitivity
- MeSH terms
- Analysis of Variance, Animals, Anxiety, Behavior, Animal, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Exploratory Behavior, Fluoxetine, Immobilization, Male, Mice, Inbred Strains, Motor Activity, Reaction Time, Species Specificity, Swimming, Time Factors, Selective Serotonin Reuptake Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.